(16 Aug 2021)
Growing global demand for cargo services has doubled
the size of China
Airlines’ cold chain logistics business.
of temperature-controlled containers transported by China Airlines
between January and July 2021 grew by 220% year-on-year, and
the outlook continues to be positive.
China Airlines was also the first carrier in Taiwan to obtain CEIV
Pharma certification for pharmaceutical cold chain logistics.
The airline has been used to transport Moderna and AstraZeneca vaccines from Luxembourg,
Amsterdam (Netherlands), Bangkok (Thailand), Memphis (USA) and
other locations back to Taiwan.
CAL’s extensive network was also used to transship
vaccines purchased by other countries to their final destinations
via Taiwan, with a number of vaccine shipments already
transshipped to other Asian countries.
According to IATA statistics, China Airlines maintained its
lead in international air cargo, with cargo volumes continuing to
grow. In 2020, China Airlines climbed into the world’s top 5
carriers by air cargo volume, carrying 1.55 million tonnes of
cargo, an increase of 12.8% compared to that of 2019.
In terms of
Freight Tonne-Kilometers (FTK), China Airlines carried 6,317
million FTK in 2020, up 18.4% from the
previous year. It was ranked 10th in the world and saw the most
growth in cargo volume out of all the top 10 carriers.
A fleet of
21 freighter aircraft including 3 newly introduced 777 freighters
and 18 existing 747 freighters helped China Airlines strengthen
its competitive edge in air cargo industry.
In the second half of 2021, China Airlines
will continue to focus on its cargo business. The 21 freighters
along with the belly holds of passenger aircraft will be used to
carry mail and packages, while particular emphasis will also be placed on the
demand for express freight, additional freighter services, and
Travel Industry News,